Reciprocal adaptation is critical in enhancing S. aureus and P. aeruginosa biofilm biomass.

Authors

Xiaohan Sun, Clare M Cooksley, Muhammed Awad, Emma F Barry, Alkis J Psaltis, Peter-John Wormald, Sarah Vreugde

Published in

Archives of microbiology. Volume 208. Issue 9. Jun 22, 2026. Epub Jun 22, 2026.

Abstract

Polymicrobial communities impose a great challenge for clinical management of chronic infections. It is a consensus now that microbes exist as aggregated colonies shielded within polymeric matrix. Within this matrix more than one bacterial species can exist either in symbiotic or rival relationships. Herein, we investigated the host-specific interspecies interactions between Staphylococcus aureus and Pseudomonas aeruginosa in chronic rhinosinusitis (CRS). The indirect interaction between the two species was assessed using Transwell co-culture chambers, where S. aureus and P. aeruginosa (n = 3 each) derived from CRS patients were cultured in separate chambers that allowed exchange of soluble factors. Later the biofilm biomass of each species was evaluated and compared to single species biofilm. Further, the influence of the co-culture conditions on antibiotic tolerance was evaluated. When derived from the same patient, co-cultured bacteria increased the biofilm biomass of each other significantly by 3.0-4.9 fold (p < 0.01) and exhibited higher tolerance to amikacin compared to co-cultures of isolates from two different patients and monocultured biofilms. Moreover, the incubation of one bacterial protein-enriched secreted fractions (PESF) with alternative species form same patient significantly increased biomass by 1.5-4.8 fold (p < 0.01), while similar trend was not observed among randomly cultured species. These data underscore the synergistic growth pattern between different bacterial species growing in the same niche and highlight the importance of further studies to aid the selection of antibiotics targeting polymicrobial biofilms.

PMID:
42329470
Bibliographic data and abstract were imported from PubMed on 22 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.